Sequential ablation of AKT1 in tobacco- and K-Ras-treated mice inhibits further lung tumor progression, and the same phenomenon has been observed in IGF-IR positive lung cancer [45,46]. This evidence concerns the gene AKT1 and lung carcinoma.